Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.06.22	Pfizer Announces Overall Survival Results from Phase 3 PALOMA-2 Trial of IBRANCE® (palbociclib) for the First-Line Treatment of ER+, HER2- Metastatic Breast Cancer (Businesswire)
01.06.22	Pfizer Provides Update on Ownership Interest in Haleon (Businesswire)
31.05.22	Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Expanding Access & Affordability (Businesswire)
26.05.22	Pfizer Granted FDA Fast Track Designation for Ervogastat/Clesacostat Combination for the Treatment of Non-Alcoholic Steatohepatitis (NASH) (Businesswire)
25.05.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
25.05.22	Pfizer Launches ‘An Accord for a Healthier World’ to Improve Health Equity for 1.2 Billion People Living in 45 Lower-Income Countries (Businesswire)
24.05.22	Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod’s Potentially Best-in-Class Profile in Ulcerative Colitis (Businesswire)
23.05.22	Tilray Brands Completes Acquisition of Atwater Brewery From Molson Coors Beverage Company (RSS)
23.05.22	Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose (Businesswire)
17.05.22	Craft Cannabis Brand, Broken Coast, Launches Latest Artisanal Strain, ‘Milk & Cookies’ for Avid Indica Enthusiasts (RSS)
17.05.22	Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age (Businesswire)
17.05.22	Statement of changes in beneficial ownership of securities (RSS)
16.05.22	4: Statement of changes in beneficial ownership of securities (RSS)
10.05.22	Pfizer to Acquire Biohaven Pharmaceuticals (Businesswire)
03.05.22	Pfizer Reports First-Quarter 2022 Results (Businesswire)
29.04.22	Form 4 78003 (RSS)
28.04.22	Pfizer Declares Second-Quarter 2022 Dividend (Businesswire)
27.04.22	Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine (Businesswire)
26.04.22	Manitoba Harvest Hemp Foods and Brightseed® Introduce New Coffee and Chocolate Flavors in Organic Bioactive Fiber Supplement for Gut Health (RSS)
26.04.22	Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate (Businesswire)
19.04.22	Pfizer Invites Shareholders to Attend Virtual-Only 2022 Annual Meeting of Shareholders on April 28 (Businesswire)
14.04.22	Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age (Businesswire)
14.04.22	Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age (RSS)
14.04.22	Form 4 78003 (RSS)
11.04.22	Pfizer Names David M. Denton Chief Financial Officer (Businesswire)
11.04.22	Additional definitive proxy soliciting materials and Rule 14(a)(12) material (RSS)
07.04.22	Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates (Businesswire)
07.04.22	Form SC 13D/A 78003 (RSS)
06.04.22	Form DEFA14A 78003 (RSS)
01.04.22	Form 4 78003 (RSS)
29.03.22	Tilray Brands, Inc. to Announce Second Quarter 2024 Financial Results on January 9, 2024 (RSS)
29.03.22	Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older (Businesswire)
29.03.22	Pfizer Announces Positive Top-line Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis, Underscoring Best-in-Class Potential (Businesswire)
28.03.22	Initial statement of beneficial ownership of securities (RSS)
24.03.22	Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV in Older Adults (Businesswire)
23.03.22	Pfizer Announces Positive Top-Line Results for Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients (Businesswire)
22.03.22	Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts (Businesswire)
22.03.22	Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries (Businesswire)
17.03.22	Additional definitive proxy soliciting materials and Rule 14(a)(12) material (RSS)
17.03.22	Form DEF 14A 78003 (RSS)
15.03.22	Celebrating Five Years of Growth: Tilray Brands Reflects on Industry Leadership in Canadian Cannabis and Looks Forward to its Future (RSS)
14.03.22	Dividenden-Aktien als Sicherheitsanker: Diese Papiere empfiehlt Jim Cramer (finanzen.ch) Angesichts der derzeitigen Marktturbulenzen könnten sich Anleger solchen Aktien zuwenden, die eine solide Dividende versprechen. Börsenguru Jim Cramer hat deshalb eine Liste von zehn Unternehmen zusammengestellt, die er in diesem Zusammenhang zum Kauf empfiehlt.» mehr
11.03.22	Pfizer Completes Acquisition of Arena Pharmaceuticals (Businesswire)
09.03.22	Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants (Businesswire)
08.03.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
01.03.22	Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints (Businesswire)
28.02.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
25.02.22	Wie Pfizer von der Coronakrise profitiert: Impfstoff und Corona-Medikament sorgen für Rekordgewinne (finanzen.ch) Einst regierte Pfizer dank seines unverhofften Kassenschlagers Viagra die Pharmabranche. Doch nach Abklingen des Hypes wurde es stiller um den US-Riesen. Die Coronakrise hat Pfizer nun jedoch wieder ganz nach vorn gebracht - der Pharmakonzern ist erfolgreicher als je zuvor.» mehr
25.02.22	Form 4 78003 (RSS)
24.02.22	8-K: Report of unscheduled material events or corporate event (RSS)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	302.80	1.30 %	K V
Alcon	76.88	0.65 %	K V
Sika	218.00	0.37 %	K V
Kuehne+Nagel Int	202.60	-0.20 %	K V
Logitech Intl	78.28	-0.33 %	K V
ABB	49.25	-1.44 %	K V
Holcim	87.68	-1.55 %	K V
Zurich Insur Gr	531.20	-1.63 %	K V
Roche Hldg G	267.20	-1.69 %	K V
UBS Group	29.78	-1.94 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Pfizer Inc Cert.Deposito Arg.Repr. 0.5 Shs

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten